close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Harmony Biosciences Holdings, Inc. - Common Stock (NQ:HRMY)

36.59 -1.34 (-3.53%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Harmony Biosciences Holdings, Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
If You Invested $1,000 in Novavax In 2020, This Is How Much You Would Have Today ↗
The stock has gone on a wild ride over the past few years. 
Via The Motley Fool
News headline image
With This Big Transition Ahead, Is Novavax a Buy? ↗
Novavax stock sank 92% last year. 
Via The Motley Fool
News headline image
2 Biotechs Making Waves With A Single Product in their Pipeline
Catalyst Pharmaceuticals and Harmony Bioscience each have a single product in their respective pipelines, and both show incredible promise. 
Via MarketBeat
News headline image
NVAX Stock Alert: What to Know as Novavax Names New CEO ↗
Although a change at the top boosted sentiment for Novavax, the harsh reality is that NVAX stock faces a mountain of worries. 
Via InvestorPlace
News headline image
Moderna Stock Shows Surprising Strength; Key Rating Upgraded ↗
See if Moderna stock forms a new pattern or follow-on buying opportunity like a three-weeks tight or pullback to the 50-day average. 
Via Investor's Business Daily
News headline image
4 Analysts Have This to Say About Harmony Biosciences ↗
Within the last quarter, Harmony Biosciences (NASDAQ:HRMY) has observed the following analyst ratings: 
Via Benzinga
News headline image
Where Harmony Biosciences Stands With Analysts ↗
Analysts have provided the following ratings for Harmony Biosciences (NASDAQ:HRMY) within the last quarter: 
Via Benzinga
News headline image
6 Analysts Have This to Say About Harmony Biosciences ↗
Harmony Biosciences (NASDAQ:HRMY) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash. 
Via Benzinga
News headline image
BeiGene Stock Shows Market Leadership With Jump To 82 RS Rating ↗
On Thursday, China-based BeiGene stock cleared that desired 80-plus benchmark, with a jump to 82 from 77 a day earlier. 
Via Investor's Business Daily
News headline image
Xenon Pharmaceuticals Stock Scores Rising Relative Strength Upgrade ↗
Xenon Pharmaceuticals stock had its Relative Strength (RS) Rating upgraded to 92 Tuesday, up from 89 a day earlier. 
Via Investor's Business Daily
News headline image
BioCryst Pharmaceuticals Stock Sees RS Rating Rise To 84 ↗
The Relative Strength (RS) Rating for BioCryst Pharmaceuticals stock climbed into a new percentile Friday, with a rise from 64 to 84. 
Via Investor's Business Daily
News headline image
Looking Into Harmony Biosciences's Return On Capital Employed ↗
According to Benzinga Pro, during Q3, Harmony Biosciences (NASDAQ:HRMY) earned $87.94 million, a 273.73% increase from the preceding quarter. Harmony Biosciences also posted a total of $117.21 million... 
Via Benzinga
News headline image
Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday ↗
Gainers 
Via Benzinga
News headline image
Gartner, Sony, Uber And Other Big Gainers From Tuesday ↗
U.S. stocks closed lower on Tuesday, with the Nasdaq Composite dropping around 100 points. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
News headline image
Harmony Biosciences Holdings, Inc. (HRMY) Q3 2022 Earnings Call Transcript ↗
HRMY earnings call for the period ending September 30, 2022. 
Via The Motley Fool
News headline image
Why IBD 50 Stock Harmony Biosciences Flew To The High End Of Its Buy Zone ↗
The third-quarter beat, alone, wasn't enough to drive the positive stock movement. 
Via Investor's Business Daily
News headline image
Recap: Harmony Biosciences Q3 Earnings ↗
Harmony Biosciences (NASDAQ:HRMY) reported its Q3 earnings results on Tuesday, November 1, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Earnings Harmony Biosciences... 
Via Benzinga
News headline image
Harmony Biosciences Reports Third Quarter 2022 Financial Results and Business Updates
From Harmony Biosciences
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Domino's Pizza To Rally 20%? Here Are 5 Other Price Target Changes For Friday ↗
Wedbush raised Domino's Pizza, Inc. (NYSE: DPZ) price target from $370 to $400. Wedbush analyst Nick Setyan maintained an Outperform rating on the stock. Domino's shares rose 10.4% to close at $333.26... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2022 ↗
  
Via Benzinga
News headline image
Stock Market Rally Mixed As Oil Prices Fall, Job Growth Hot: Weekly Review ↗
The Nasdaq and small caps rose while the S&P 500 is hitting resistance. 
Via Investor's Business Daily
News headline image
Harmony Biosciences Makes Leap Out Of Buy Zone After Narcolepsy Drug Drives Beat ↗
Shares surged well above the 5% chase zone in early action Tuesday. 
Via Investor's Business Daily
News headline image
Harmony Biosciences: Q2 Earnings Insights ↗
  Harmony Biosciences (NASDAQ:HRMY) reported its Q2 earnings results on Tuesday, August 2, 2022 at 07:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
  
Via Benzinga
News headline image
Preview: Harmony Biosciences's Earnings ↗
Harmony Biosciences (NASDAQ:HRMY) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that Harmony... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2022 ↗
Upgrades 
Via Benzinga
News headline image
EXCLUSIVE: Has Biotech Bottomed? NYSE Executive Floor Director Says Biogen And These 3 Stocks Look Poised To Outperform ↗
Markets continue to trend lower amid rising inflation and Fed uncertainty, but one New York Stock Exchange floor director says the bottom may be in for a couple of beaten-down sectors. 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today